X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (121) 121
nesidioblastosis (111) 111
female (76) 76
male (66) 66
hypoglycemia (59) 59
infant, newborn (53) 53
infant (50) 50
index medicus (49) 49
pancreatectomy (48) 48
endocrinology & metabolism (47) 47
pediatrics (37) 37
hypoglycemia - etiology (35) 35
surgery (34) 34
infancy (31) 31
adult (28) 28
hyperinsulinism - drug therapy (27) 27
hypoglycemia - drug therapy (26) 26
treatment outcome (26) 26
hyperinsulinemic hypoglycemia (25) 25
glucose (22) 22
hyperinsulinism (21) 21
insulin (21) 21
insulin-secretion (21) 21
pancreas (20) 20
child, preschool (19) 19
diazoxide - therapeutic use (19) 19
congenital hyperinsulinism (18) 18
familial hyperinsulinism (18) 18
medicine & public health (18) 18
octreotide - therapeutic use (18) 18
hyperinsulinism - surgery (17) 17
insulin - blood (17) 17
middle aged (17) 17
mutation (17) 17
child (16) 16
children (16) 16
hyperinsulinism - complications (16) 16
hypoglycemia - diagnosis (16) 16
management (16) 16
octreotide (16) 16
blood glucose - metabolism (15) 15
diagnosis (15) 15
gastric bypass - adverse effects (15) 15
hyperinsulinism - genetics (15) 15
mutations (15) 15
adolescent (14) 14
diabetes (14) 14
follow-up studies (14) 14
gastric bypass (14) 14
insulinoma (14) 14
obesity (14) 14
animals (13) 13
hypoglycaemia (13) 13
persistent hyperinsulinemic hypoglycemia (13) 13
potassium channels - genetics (13) 13
retrospective studies (13) 13
abridged index medicus (12) 12
bariatric surgery (12) 12
blood glucose - analysis (12) 12
hyperinsulinism - diagnosis (12) 12
nesidioblastosis - diagnosis (12) 12
noninsulinoma pancreatogenous hypoglycemia (12) 12
pancreas - pathology (12) 12
sulfonylurea receptors (12) 12
dextrose (11) 11
diazoxide (11) 11
hyperinsulinism - etiology (11) 11
hypoglycemia - surgery (11) 11
islets of langerhans - pathology (11) 11
pancreatic diseases - surgery (11) 11
congenital hyperinsulinism - genetics (10) 10
gene (10) 10
glucose tolerance test (10) 10
health aspects (10) 10
hyperinsulinism - congenital (10) 10
hypoglycemia - genetics (10) 10
hypoglycemia - therapy (10) 10
receptors, drug - genetics (10) 10
care and treatment (9) 9
glucagon-like peptide-1 (9) 9
hypoglycemia - blood (9) 9
insulin - metabolism (9) 9
nesidioblastosis - drug therapy (9) 9
sulfonylurea receptor (9) 9
therapy (9) 9
adults (8) 8
atp-binding cassette transporters (8) 8
congenital hyperinsulinism - drug therapy (8) 8
diagnosis, differential (8) 8
gastric-bypass-surgery (8) 8
hyperinsulinism - blood (8) 8
hyperinsulinism - pathology (8) 8
insulin secretion (8) 8
internal medicine (8) 8
k-atp channel (8) 8
neonatal hypoglycemia (8) 8
nesidioblastosis - surgery (8) 8
pancreatectomy - methods (8) 8
potassium channels, inwardly rectifying - genetics (8) 8
somatostatin (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2010, Volume 147, Issue 5, pp. 664 - 669
Journal Article
Medicine, ISSN 0025-7974, 04/2016, Volume 95, Issue 14, p. e3272
Nesidioblastosis is a rare cause of endogenous hyperinsulinemic hypoglycemia in adults. Diagnosis is often challenging and therapeutic options are scarce.In... 
Somatostatin - analogs & derivatives | Time Factors | Humans | Middle Aged | Female | Nesidioblastosis - drug therapy | Somatostatin - therapeutic use | Remission Induction
Journal Article
Journal of Pediatric Endocrinology and Metabolism, ISSN 0334-018X, 11/2013, Volume 26, Issue 11, pp. 1153 - 1156
Journal Article
Journal Article
Journal Article
Journal Article
Hormone Research in Paediatrics, ISSN 1663-2818, 07/2008, Volume 70, Issue 1, pp. 59 - 64
Background: Congenital hyperinsulinism (CHI) is characterized by severe hypoglycemia caused by dysregulated insulin secretion. The long-term outcome is... 
Novel Insights from Clinical Practice | Congenital hyperinsulinism | Continuous subcutaneous glucagon infusion | Diazoxide-resistant congenital hyperinsulinism | Octreotide and subcutaneous glucagon infusion | Severe persistent congenital hyperinsulinism | Hypoglycemic episodes | OCTREOTIDE | PANCREATECTOMY | congenital hyperinsulinism | NESIDIOBLASTOSIS | SUPPRESSION | octreotide and subcutaneous glucagon infusion | CHILDREN | hypoglycemic episodes | NEONATAL HYPERINSULINISM | continuous subcutaneous glucagon infusion | SOMATOSTATIN | ENDOCRINOLOGY & METABOLISM | HYPOGLYCEMIA | severe persistent congenital hyperinsulinism | diazoxide-resistant congenital hyperinsulinism | CELL SULFONYLUREA RECEPTOR | INFANCY | Brain Diseases, Metabolic - prevention & control | Blood Glucose - analysis | Humans | Gastrointestinal Agents - administration & dosage | Pancreatectomy | Congenital Hyperinsulinism - complications | Glucagon - administration & dosage | Octreotide - adverse effects | Male | Brain Diseases, Metabolic - blood | Hypoglycemia - prevention & control | Glycogen - metabolism | Congenital Hyperinsulinism - blood | Congenital Hyperinsulinism - drug therapy | Female | Gastrointestinal Agents - adverse effects | Hypoglycemia - blood | Retrospective Studies | Octreotide - administration & dosage | Glucagon - adverse effects | Infant, Newborn | Index Medicus
Journal Article